Skip to main content
OpenTrials
Completed

NCT Number: NCT02093338

L.Fermentum CECT5716 in Treatment of Breast Pain

The main objective of this intervention study is to evaluate the efficacy of Lactobacillus fermentum CECT5716 to reduce the presence in the milk of genera Staphylococcus and Streptococcus as risk factors for mastitis in women with breast pain

Completed

Looking for future studies?

Notify Me

Key information

About this study

  • Type of study Nutritional intervention study, multicenter, randomized, blinded, parallel group included 25 women per group
  • Group 1: 3x109 cfu / day (n = 25)
  • Group 2: 6x109 cfu / day (n = 25)
  • Group 3: 9x109 cfu / day (n = 25)
  • Group 4: placebo (n = 25)
  • Statistical calculation of sample size. The calculation of sample size was calculated by the company SEPLIN Solutions Statistics. The primary endpoint was the bacterial count of in milk. The sample size obtained to observe a difference of 1 log10, with a power of 0.80 and a significance level of 0.05 was 20 volunteers per group.
  • Randomization Randomization was performed using a list of random numbers generated by computer. Subjects will be randomized in a strictly sequential.

If a subject is removed from the test, the number that was assigned randomization not be reused again.

  • Overall design and outline of the study At visit 1 we require the informed consent of the patient. It will take the milk sample, we will review the implementation of the inclusion and exclusion criteria. Be randomized and explain the treatment guidelines to be followed, the data to be collected and medical appointments that must go (2 and 3 weeks). It will complete the pain assessment questionnaire (MQP) and nutrition survey.

On visits 2, 3 and 4 corresponding to 1, 2 and 3 weeks of intervention will collect milk sample pain assessment survey and nutrition survey.

Milk samples (5 mL) were collected aseptically in sterile tubes to be frozen immediately until analysis to be carried out within seven days.

  • Intervention duration The intervention will last three weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

· breast-feeding women

  • Swelling and / or warmth in the chest
  • Chest pain
  • total bacteria count in milk greater than or equal to 3 log10 colony forming units (CFU) / mL,

Exclusion criteria

  • breast abscesses, Raynaud syndrome,
  • Antibiotic treatment
  • Allergic to antibiotics
  • Low expectation of compliance with the study protocol.

Treatment and study plan

Lactobacillus fermentum CECT5716

Dietary Supplement

Placebo Comparator: maltodextrin

Other

Placebo

Primary outcomes

  1. Change from baseline Staphylococcus count at 3 weeks

    Time frame: 0, 3 weeks

    Counts of Staphylococcus in breast milk

Secondary outcomes

  1. Change from baseline Streptococcus counts at 3 weeks

    Time frame: 0, 3 weeks

    Streptococcus counts in breast milk

  2. Change from Breast pain score at 3 weeks

    Time frame: 0, 3 weeks

    evaluation of breast pain

Sponsors and collaborators

Lead sponsor

Biosearch S.A.

Industry

Collaborators

  • Junta de Andalucia
  • Statistical analysis: SEPLIN Soluciones Estadísticas

Registry information

Official study title

Study of Intervention Nutritional, Multicenter, Randomized, Blind, Parallel Group to Evaluate the Efficacy of Lactobacillus Fermentum CECT5716 to Reduce the Load Bacterial in Potential Pathogens in Milk of Mothers With Breast Pain

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Mar 21, 2014
Registry last updated
Mar 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.